Treatment of congenital Langerhans cell histiocytosis with cobimetinib

被引：2

作者：

Benjelloun, Ghita ^{[1
]}

Roquet-Gravy, Charlotte ^{[2
]}

Marot, Liliane ^{[3
]}

Secco, Leo-Paul ^{[3
]}

Roquet-Gravy, Pierre-Paul ^{[1
]}

Baeck, Marie ^{[2
]}

Bulinckx, Audrey ^{[1
,4
]}

机构：

[1] Grand Hop Charleroi, Dept Dermatol, Charleroi, Belgium

[2] Clin Univ St Luc, Dept Dermatol, Brussels, Belgium

[3] Clin Univ St Luc, Dept Anatomopathol, Brussels, Belgium

[4] Grand Hop Charleroi, Dept Dermatol, GrandRue 3, B-6000 Charleroi, Belgium

来源：

PEDIATRIC DERMATOLOGY | 2024年 / 41卷 / 03期

关键词：

BRAF V600E mutation; cobimetinib; congenital Langerhans cell histiocytosis; MEK mutation; BRAF; MUTATIONS; DISEASE; MAP2K1;

D O I：

10.1111/pde.15512

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

We report a case of congenital multisystem Langerhans cell histiocytosis with cutaneous and hematopoietic involvement. After the failure of first-line (vinblastine and prednisolone) and second-line (vincristine and cytarabine) therapies, treatment with cobimetinib, a mitogen-activated protein kinase (MEK) inhibitor, led to the remission of disease and a sustained response after 11 months of ongoing treatment. Protein kinase inhibitors targeting BRAF or MEK could represent a promising future therapeutic option, also in children with LCH.

引用

页码：515 / 517

页数：3

共 50 条

[31] Genomic Alterations in Langerhans Cell Histiocytosis
Rollins, Barrett J.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (05) : 839 - +
[32] Diverse Cutaneous Presentations of Langerhans Cell Histiocytosis in Children: A Retrospective Cohort Study
Morren, Marie-Anne
Vanden Broecke, Katrien
Vangeebergen, Leen
Sillevis-Smitt, Johannes Henk
Van Den Berghe, Peter
Hauben, Esther
Jacobs, Sandra
Van Gool, Stefaan W.
PEDIATRIC BLOOD & CANCER, 2016, 63 (03) : 486 - 492
[33] Pulmonary manifestations of Langerhans cell histiocytosis
Obert, J.
Tazi, A.
REVUE DES MALADIES RESPIRATOIRES, 2015, 32 (08) : 850 - 866
[34] Blood spotlight on Langerhans cell histiocytosis
Delprat, Christine
Arico, Maurizio
BLOOD, 2014, 124 (06) : 867 - 872
[35] Characteristics and Treatment Outcomes of Pediatric Langerhans Cell Histiocytosis with Thymic Involvement
Yao, Ja-Feng
Wang, Dong
Ma, Hong-Hao
Lian, Hong-Yun
Zhang, Li
Wang, Tian-You
Li, Zhi-Gang
Jiang, Jin
Cui, Lei
Zhang, Rui
JOURNAL OF PEDIATRICS, 2022, 244 : 194 - +
[36] Multifocal Oral Langerhans Cell Histiocytosis
Murray, Matthew
Dean, Jeffrey
Slater, Lee
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2011, 69 (10) : 2585 - 2591
[37] Neurodegeneration in the course of Langerhans cell histiocytosis
Spagnolo, F.
Leopizzi, E.
Cardamone, R.
Falautano, M.
Martinelli, V.
Comi, G.
Volonte, M. A.
NEUROLOGICAL SCIENCES, 2012, 33 (03) : 605 - 607
[38] Pulmonary Langerhans cell histiocytosis in adults
Feuillet, Severine
Giroux-Leprieur, Benedicte
Tazi, Abdellatif
PRESSE MEDICALE, 2010, 39 (01): : 107 - 115
[39] Langerhans cell histiocytosis in Turkish children
Tokuc, Guelnuer
Boran, Perran
Oktem, Sedat
TURKISH JOURNAL OF PEDIATRICS, 2009, 51 (04) : 344 - 349
[40] Recent advances in Langerhans cell histiocytosis
Morimoto, Akira
Oh, Yukiko
Shioda, Yoko
Kudo, Kazuko
Imamura, Toshihiko
PEDIATRICS INTERNATIONAL, 2014, 56 (04) : 451 - 461

← 1 2 3 4 5 →